| CVO group (38 hips) | Control group (30 hips) | p value |
---|---|---|---|
Age at CVO (months) | 34.5 [26.5–41.8] | 35.5 [31.3–41.8] | 0.688a |
Age at simulation (months) | 45.0 [35.3–52.8] | 44.4 [38.0–52.3] | 0.980a |
Follow-up duration after CVO (months) | 120.0 [27.5–192.8] | 106.0 [12.0–188.5] | 0.354a |
Sex (female/male) | 21/17 | 14/16 | 0.494b |
Height (cm) | 167.0 [156.3–170.8] | 168.0 [157.3–171.0] | 0.473a |
Weight (kg) | 61.8 [53.0–75.0] | 65.5 [53.3–75.8] | 0.753a |
BMI (kg/m2) | 22.7 [20.2–26.9] | 22.7 [19.6–26.4] | 0.970a |